J. Homewood

Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

K. Inglis, D. Cottrell, P. White, 2018, BMC Neurology.

Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.

P. Walsh, N. Kane, K. Inglis, 2015, Multiple sclerosis and related disorders.